HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bioactivity-guided isolation of 1,2,3,4,6-Penta-O-galloyl-D-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor.

Abstract
The inhibition of protein tyrosine phosphatase 1B (PTP1B) is of substantial interest for the treatment of type-2 diabetes mellitus. Using an in vitro enzyme assay with human recombinant PTP1B 1,2,3,4,6-penta-O-galloyl-D-glucopyranose was isolated from the roots of Paeonia lactiflora as an inhibitor of PTP1B, with an IC(50) value of 4.8 μM. Additionally, 1 was shown to act as an insulin sensitizer in human hepatoma cells (HCC-1.2) at a concentration of 10 μM. Thus, a potential new mechanism of action is provided explaining the antidiabetic properties of P. lactiflora.
AuthorsRenate R Baumgartner, Dirk Steinmann, Elke H Heiss, Atanas G Atanasov, Markus Ganzera, Hermann Stuppner, Verena M Dirsch
JournalJournal of natural products (J Nat Prod) Vol. 73 Issue 9 Pg. 1578-81 (Sep 24 2010) ISSN: 1520-6025 [Electronic] United States
PMID20806783 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydrolyzable Tannins
  • Hypoglycemic Agents
  • Insulin
  • pentagalloylglucose
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
Topics
  • Austria
  • Carcinoma, Hepatocellular (metabolism)
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Enzyme Assays
  • Humans
  • Hydrolyzable Tannins (chemistry, isolation & purification, pharmacology)
  • Hypoglycemic Agents (chemistry, isolation & purification, pharmacology)
  • Insulin (metabolism)
  • Paeonia (chemistry)
  • Plant Roots (chemistry)
  • Plants, Medicinal (chemistry)
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: